Key market opportunities for Heplisav-B include expansion of adult vaccination mandates, focus on diabetic and liver disease patients, adoption by integrated delivery networks, and workplace vaccination programs. Innovative adjuvanted vaccines enhance immune …
Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Heplisav-B Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
… [+3674 chars]
